Atrioventricular Node Dysfunction in Heart Failure: New Horizons from Pathophysiology to Therapeutic Perspectives

  • Isabella Fumarulo
  • , Elia Nunzio Maria Salerno
  • , Andrea De Prisco
  • , Salvatore Emanuele Ravenna
  • , Maria Chiara Grimaldi
  • , Francesco Burzotta
  • , Nadia Aspromonte*
  • *Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Heart failure (HF) is characterized by adverse myocardial remodeling involving both the contractile cardiomyocytes and the conduction tissue. HF is often associated with atrioventricular (AV) node dysfunction, which frequently leads to conduction delays and subsequent dyssynchrony ultimately related to adverse clinical outcomes. Despite its clinical relevance, AV node pathology in HF remains poorly explored. This review aims to investigate the pathophysiology underlying AV node dysfunction and the clinical implications for patients with HF, and to provide an overview of current therapeutic approaches, including an analysis of potential future treatments.
Lingua originaleInglese
pagine (da-a)N/A-N/A
RivistaJournal of Cardiovascular Development and Disease
Volume12
Numero di pubblicazione8
DOI
Stato di pubblicazionePubblicato - 2025

All Science Journal Classification (ASJC) codes

  • Farmacologia, Tossicologia e Farmaceutica Generali
  • Farmacologia (medica)

Keywords

  • atrioventricular node
  • cardiac resynchronization therapy
  • heart failure

Fingerprint

Entra nei temi di ricerca di 'Atrioventricular Node Dysfunction in Heart Failure: New Horizons from Pathophysiology to Therapeutic Perspectives'. Insieme formano una fingerprint unica.

Cita questo